CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

1547 results.
Operations
Selected 22 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C01582 Height unit of measure

Unit of measure for the height numerical value for participant

Supplemental-Highly Recommended Vital Signs Stroke Stroke
C11131 Body mass index value

Value of the participant's body mass index, calculated from height and weight

Supplemental Vital Signs Stroke Stroke
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Core Vital Signs Stroke Stroke
C01507 Blood pressure diastolic measurement

Measurement of pressure of the participant's blood against the artery walls during diastole (the relaxation phase) in millimeters of mercury (mmHg)

Core Vital Signs Stroke Stroke
C01553 Blood pressure measurement position type

Indicator of the participant's position during the blood pressure measurement

Supplemental Vital Signs Stroke Stroke
C01521 Heart rate

The participant's pulse or number of contractions (heart beats) per minute

Core Vital Signs Stroke Stroke
C01535 Respiratory rate

Rate of the participant's breathing (inhalation and exhalation)

Supplemental-Highly Recommended Vital Signs Stroke Stroke
C02496 Imaging scanner manufacturer name

Name of manufacturer of imaging scanner

Supplemental Imaging Acquisition Stroke Stroke
C18718 Imaging scanner strength value type other text

The free-text field related to 'Imaging scanner strength value type', specifying other text. Type of value, in Tesla (T), of the scanner's magnetic field strength used for the scan being reported

Supplemental Imaging Acquisition Stroke Stroke
C01705 Lab test name

Name representing the lab test performed on body fluid(s) and tissues. Test names are typically comprised of the analyte name, properties (%, Ratio, etc.), the type of body fluid tested, and any special instructions

Supplemental-Highly Recommended Biospecimen Collection and Processing Stroke Stroke
C02498 Imaging scanner software version number text

Free-text field specifying the version number of the imaging scanner software

Supplemental Imaging Acquisition Stroke Stroke
C01705 Lab test name

Name representing the lab test performed on body fluid(s) and tissues. Test names are typically comprised of the analyte name, properties (%, Ratio, etc.), the type of body fluid tested, and any special instructions

Supplemental Laboratory Tests Stroke Stroke
C10570 Imaging contrast agent used indicator

Indicator of whether an imaging contrast agent was used for the scan

Supplemental Vessel Imaging Transcranial Stroke Stroke
C10570 Imaging contrast agent used indicator

Indicator of whether an imaging contrast agent was used for the scan

Supplemental Vessel Carotid Ultrasound Stroke Stroke
C18718 Imaging scanner strength value type other text

The free-text field related to 'Imaging scanner strength value type', specifying other text. Type of value, in Tesla (T), of the scanner's magnetic field strength used for the scan being reported

Supplemental Parenchymal Imaging Stroke Stroke
C60360 IV thrombolytic agent total dose

Dose of IV thrombolytic agent, in mg, given to the participant

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
C60361 IV thrombolytic agent type

Type of IV thrombolytic agent given to the participant

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
C60362 IV thrombolytic agent type other text

The free-text field related to 'IV thrombolytic agent type' specifying other text.

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
C60363 IV thrombolytic agent not started reason

If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital.

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
C60364 IV thrombolytic agent not started other text

The free-text field related to 'IV thrombolytic agent not started reason' specifying other text. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital.

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
C60365 IV thrombolytic agent not started MRI selection treatment beyond 4.5 hour reason

If NO Intravenous thrombolytic agent was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital.

Exploratory Thrombolytic/Reperfusion Therapies Stroke Stroke
C60366 IV thrombolytic agent at another hospital indicator

Indicator of whether IV thrombolytic agent was initiated for the participant at an outside hospital

Supplemental Thrombolytic/Reperfusion Therapies Stroke Stroke
1547 results.

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.